227 related articles for article (PubMed ID: 24971600)
1. GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.
Filip M; Frankowska M; Sadakierska-Chudy A; Suder A; Szumiec L; Mierzejewski P; Bienkowski P; Przegaliński E; Cryan JF
Neuropharmacology; 2015 Jan; 88():36-47. PubMed ID: 24971600
[TBL] [Abstract][Full Text] [Related]
2. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
Agabio R; Colombo G
Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
[TBL] [Abstract][Full Text] [Related]
3. GABA
de Miguel E; Vekovischeva O; Kuokkanen K; Vesajoki M; Paasikoski N; Kaskinoro J; Myllymäki M; Lainiola M; Janhunen SK; Hyytiä P; Linden AM; Korpi ER
Addict Biol; 2019 Nov; 24(6):1191-1203. PubMed ID: 30421860
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Potential of Positive Allosteric Modulators of the GABAB Receptor to Treat Alcohol Use Disorder.
Augier E
Alcohol Alcohol; 2021 Feb; 56(2):139-148. PubMed ID: 33561865
[TBL] [Abstract][Full Text] [Related]
5. The GABAB receptor-positive modulator GS39783 and the GABAB receptor agonist baclofen attenuate the reward-facilitating effects of cocaine: intracranial self-stimulation studies in the rat.
Slattery DA; Markou A; Froestl W; Cryan JF
Neuropsychopharmacology; 2005 Nov; 30(11):2065-72. PubMed ID: 15841108
[TBL] [Abstract][Full Text] [Related]
6. Targeting GABAB receptors for anti-abuse drug discovery.
Phillips TJ; Reed C
Expert Opin Drug Discov; 2014 Nov; 9(11):1307-17. PubMed ID: 25195620
[TBL] [Abstract][Full Text] [Related]
7. Potential of GABA
Maccioni P; Colombo G
CNS Drugs; 2019 Feb; 33(2):107-123. PubMed ID: 30604283
[TBL] [Abstract][Full Text] [Related]
8. GABAB receptors in reward processes.
Vlachou S; Markou A
Adv Pharmacol; 2010; 58():315-71. PubMed ID: 20655488
[TBL] [Abstract][Full Text] [Related]
9. The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.
Jacobson LH; Vlachou S; Slattery DA; Li X; Cryan JF
Biol Psychiatry; 2018 Jun; 83(11):963-976. PubMed ID: 29759132
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of GABA(B) receptor ligands in drug addiction, anxiety, depression and other CNS disorders.
Kumar K; Sharma S; Kumar P; Deshmukh R
Pharmacol Biochem Behav; 2013 Sep; 110():174-84. PubMed ID: 23872369
[TBL] [Abstract][Full Text] [Related]
11. Clinical potential of GABAB receptor modulators.
Ong J; Kerr DI
CNS Drug Rev; 2005; 11(3):317-34. PubMed ID: 16389296
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation by the GABAB receptor allosteric potentiator 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethylpropyl)-phenol (CGP7930) of synaptic transmission in the rat hippocampal CA1 area.
Chen Y; Menendez-Roche N; Sher E
J Pharmacol Exp Ther; 2006 Jun; 317(3):1170-7. PubMed ID: 16507713
[TBL] [Abstract][Full Text] [Related]
13. KK-92A, a novel GABA
Li X; Sturchler E; Kaczanowska K; Cameron M; Finn MG; Griffin P; McDonald P; Markou A
Psychopharmacology (Berl); 2017 May; 234(9-10):1633-1644. PubMed ID: 28382542
[TBL] [Abstract][Full Text] [Related]
14. GABA
Li X; Slesinger PA
Curr Top Behav Neurosci; 2022; 52():119-155. PubMed ID: 33442842
[TBL] [Abstract][Full Text] [Related]
15. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
17. Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA(B) receptor.
Castelli MP; Casu A; Casti P; Lobina C; Carai MA; Colombo G; Solinas M; Giunta D; Mugnaini C; Pasquini S; Tafi A; Brogi S; Gessa GL; Corelli F
J Pharmacol Exp Ther; 2012 Mar; 340(3):529-38. PubMed ID: 22129594
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacological characterization of SSD114, a novel GABAB positive allosteric modulator.
Porcu A; Lobina C; Giunta D; Solinas M; Mugnaini C; Castelli MP
Eur J Pharmacol; 2016 Nov; 791():115-123. PubMed ID: 27578262
[TBL] [Abstract][Full Text] [Related]
19. GABA
Holtyn AF; Weerts EM
Curr Top Behav Neurosci; 2022; 52():157-194. PubMed ID: 32808090
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and side effects of baclofen and the novel GABA
Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
